{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:57:19Z","timestamp":1790906239238,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Neurobiology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.conb.2021.11.006","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T05:25:33Z","timestamp":1638854733000},"page":"155-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Recent research in fragile X-associated tremor\/ataxia syndrome"],"prefix":"10.1016","volume":"72","author":[{"given":"Maria Jimena","family":"Salcedo-Arellano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi J.","family":"Hagerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conb.2021.11.006_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrneurol.2016.82","article-title":"Fragile X-associated tremor\/ataxia syndrome - features, mechanisms and management","volume":"12","author":"Hagerman","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.conb.2021.11.006_bib2","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jamaneurol.2015.1138","article-title":"Fragile X\u2013associated tremor\/ataxia syndrome in a man in his 30s","volume":"72","author":"Mart\u00ednez-Cerde\u00f1o","year":"2015","journal-title":"JAMA neurology"},{"key":"10.1016\/j.conb.2021.11.006_bib3","doi-asserted-by":"crossref","first-page":"720253","DOI":"10.3389\/fnins.2021.720253","article-title":"Case report: coexistence of alzheimer-type neuropathology in fragile X-associated tremor ataxia syndrome","volume":"15","author":"Salcedo-Arellano","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.conb.2021.11.006_bib4","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/mds.28559","article-title":"Cerebral microbleeds in fragile X-associated tremor\/ataxia syndrome","volume":"36","author":"Salcedo-Arellano","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.conb.2021.11.006_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/ANA.0000000000000508","article-title":"General anesthetic use in fragile X spectrum disorders","volume":"31","author":"Ligsay","year":"2019","journal-title":"J\u00a0Neurosurg Anesthesiol"},{"key":"10.1016\/j.conb.2021.11.006_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/302720","article-title":"Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome","volume":"66","author":"Tassone","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.conb.2021.11.006_bib7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3389\/fpsyt.2018.00564","article-title":"Fragile X-associated neuropsychiatric disorders (FXAND)","volume":"9","author":"Hagerman","year":"2018","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.conb.2021.11.006_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/gm401","article-title":"FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States","volume":"4","author":"Tassone","year":"2012","journal-title":"Genome Med"},{"key":"10.1016\/j.conb.2021.11.006_bib9","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/ejhg.2009.51","article-title":"Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families","volume":"17","author":"Rodriguez-Revenga","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.conb.2021.11.006_bib10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.291.4.460","article-title":"Penetrance of the fragile x\u2013associated tremor\/ataxia syndrome in a premutation carrier population","volume":"291","author":"Jacquemont","year":"2004","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.conb.2021.11.006_bib11","article-title":"Emerging topics in FXTAS","volume":"6","author":"Hall","year":"2014","journal-title":"J\u00a0Neurodev Disord"},{"key":"10.1016\/j.conb.2021.11.006_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/brainsci11010013","article-title":"Upper and lower limb movement kinematics in aging FMR1 gene premutation carriers","volume":"11","author":"Wang","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.conb.2021.11.006_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1109\/TNSRE.2010.2047606","article-title":"iTUG, a sensitive and reliable measure of mobility","volume":"18","author":"Salarian","year":"2010","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"key":"10.1016\/j.conb.2021.11.006_bib14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12311-015-0714-4","article-title":"Gait and functional mobility deficits in fragile X-associated tremor\/ataxia syndrome","volume":"15","author":"O'Keefe","year":"2016","journal-title":"Cerebellum"},{"key":"10.1016\/j.conb.2021.11.006_bib15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fneur.2019.00832","article-title":"Total and regional white matter lesions are correlated with motor and cognitive impairments in carriers of the FMR1 premutation","volume":"10","author":"Hocking","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.conb.2021.11.006_bib16","doi-asserted-by":"crossref","first-page":"102332","DOI":"10.1016\/j.nicl.2020.102332","article-title":"Cerebellar-cortical function and connectivity during sensorimotor behavior in aging FMR1 gene premutation carriers","volume":"27","author":"McKinney","year":"2020","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.conb.2021.11.006_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2017.03.018","article-title":"Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation","volume":"55","author":"Wang","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.conb.2021.11.006_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archneurol.2011.2023","article-title":"Age-dependent structural connectivity effects in fragile x premutation","volume":"69","author":"Wang","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.conb.2021.11.006_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neurobiolaging.2019.09.009","article-title":"Interaction between ventricular expansion and structural changes in the corpus callosum and putamen in males with FMR1 normal and premutation alleles","volume":"86","author":"Wang","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.conb.2021.11.006_bib20","doi-asserted-by":"crossref","first-page":"16676","DOI":"10.1096\/fj.202001880R","article-title":"Metabolic profiling reveals dysregulated lipid metabolism and potential biomarkers associated with the development and progression of Fragile X-Associated Tremor\/Ataxia Syndrome (FXTAS)","volume":"34","author":"Zafarullah","year":"2020","journal-title":"Faseb J"},{"key":"10.1016\/j.conb.2021.11.006_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.577246","article-title":"Differential progression of motor dysfunction between male and female fragile X premutation carriers reveals novel aspects of sex-specific neural involvement","volume":"7","author":"Loesch","year":"2021","journal-title":"Frontiers in molecular biosciences"},{"key":"10.1016\/j.conb.2021.11.006_bib22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/mdc3.13084","article-title":"Women with fragile X-associated tremor\/ataxia syndrome","volume":"7","author":"Schneider","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.conb.2021.11.006_bib23","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1096\/fj.201600315R","article-title":"Warburg effect linked to cognitive-executive deficits in FMR1 premutation","volume":"30","author":"Napoli","year":"2016","journal-title":"Faseb J"},{"key":"10.1016\/j.conb.2021.11.006_bib24","doi-asserted-by":"crossref","first-page":"578640","DOI":"10.3389\/fmolb.2020.578640","article-title":"Characterization of the metabolic, clinical and neuropsychological phenotype of female carriers of the premutation in the X-linked FMR1 gene","volume":"7","author":"Napoli","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.conb.2021.11.006_bib25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mdc3.12944","article-title":"A\u00a0case of generalized chorea presenting as an early feature of fragile-X associated tremor\/ataxia syndrome","volume":"7","author":"Islam","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.conb.2021.11.006_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12883-020-01726-z","article-title":"A\u00a0Chinese case of fragile X-associated tremor\/ataxia syndrome (FXTAS) with orthostatic tremor:case report and literature review on tremor in FXTAS","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Neurol"},{"key":"10.1016\/j.conb.2021.11.006_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8050136","article-title":"Ataxia as the major manifestation of fragile X-associated tremor\/ataxia syndrome (FXTAS): case series","volume":"8","author":"Salcedo-Arellano","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.conb.2021.11.006_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/CIA.S240314","article-title":"Rapidly progressing neurocognitive disorder in a male with FXTAS and alzheimer's disease","volume":"15","author":"Aydin","year":"2020","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.conb.2021.11.006_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41398-020-00863-w","article-title":"Elevated FMR1-mRNA and lowered FMRP - a double-hit mechanism for psychiatric features in men with FMR1 premutations","volume":"10","author":"Schneider","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.conb.2021.11.006_bib30","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1136\/jmg.2003.012518","article-title":"Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor\/ataxia syndrome","volume":"41","author":"Tassone","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.conb.2021.11.006_bib31","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/brain\/awf184","article-title":"Neuronal intranuclear inclusions in a new cerebellar tremor\/ataxia syndrome among fragile X carriers","volume":"125","author":"Greco","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.11.006_bib32","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s12311-016-0776-y","article-title":"A\u00a0majority of FXTAS cases present with intranuclear inclusions within Purkinje cells","volume":"15","author":"Ariza","year":"2016","journal-title":"Cerebellum"},{"key":"10.1016\/j.conb.2021.11.006_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/brain\/awh683","article-title":"Neuropathology of fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"129","author":"Greco","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.11.006_bib34","first-page":"1434","article-title":"Testicular and pituitary inclusion formation in fragile X associated tremor\/ataxia syndrome","volume":"177","author":"Greco","year":"2007","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.conb.2021.11.006_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00401-011-0860-9","article-title":"Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor\/ataxia syndrome and CGG knock-in mice","volume":"122","author":"Hunsaker","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.conb.2021.11.006_bib36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mds.26902","article-title":"Iron accumulation and dysregulation in the putamen in fragile X-associated tremor\/ataxia syndrome","volume":"32","author":"Ariza","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.conb.2021.11.006_bib37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12311-016-0798-5","article-title":"Cerebellar mild iron accumulation in a subset of FMR1 premutation carriers with FXTAS","volume":"15","author":"Rogers","year":"2016","journal-title":"Cerebellum"},{"key":"10.1016\/j.conb.2021.11.006_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2014.11.058","article-title":"Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor\/ataxia syndrome","volume":"1598","author":"Ariza","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.conb.2021.11.006_bib39","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/mds.27553","article-title":"Microglial cell activation and senescence are characteristic of the pathology FXTAS","volume":"33","author":"Mart\u00ednez Cerde\u00f1o","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.conb.2021.11.006_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.parkreldis.2020.11.026","article-title":"FXTAS presents with upregulation of the cytokines IL12 and TNFalpha","volume":"82","author":"Dufour","year":"2020","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.conb.2021.11.006_bib41","doi-asserted-by":"crossref","first-page":"104740","DOI":"10.1016\/j.nbd.2020.104740","article-title":"Fragile X syndrome and associated disorders: clinical aspects and pathology","volume":"136","author":"Salcedo-Arellano","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2021.11.006_bib42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1601-183X.2012.00779.x","article-title":"Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS","volume":"11","author":"Tassone","year":"2012","journal-title":"Gene Brain Behav"},{"key":"10.1016\/j.conb.2021.11.006_bib43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s40478-019-0818-z","article-title":"Fragile X-associated tremor ataxia syndrome with co-occurrent progressive supranuclear palsy-like neuropathology","volume":"7","author":"Sacino","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.conb.2021.11.006_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fgene.2018.00317","article-title":"Pathological study of a FMR1 premutation carrier with progressive supranuclear palsy","volume":"9","author":"Paucar","year":"2018","journal-title":"Front Genet"},{"key":"10.1016\/j.conb.2021.11.006_bib45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/mdc3.12942","article-title":"Parkinsonism versus concomitant Parkinson's disease in fragile X-associated tremor\/ataxia syndrome","volume":"7","author":"Salcedo-Arellano","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.conb.2021.11.006_bib46","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/mds.27420","article-title":"Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females","volume":"33","author":"Loesch","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.conb.2021.11.006_bib47","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/cge.12070","article-title":"New evidence for, and challenges in, linking small CGG repeat expansion FMR1 alleles with Parkinson's disease","volume":"84","author":"Loesch","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.conb.2021.11.006_bib48","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.parkreldis.2014.01.006","article-title":"Parkinsonism in fragile X-associated tremor\/ataxia syndrome (FXTAS): revisited","volume":"20","author":"Niu","year":"2014","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.conb.2021.11.006_bib49","doi-asserted-by":"crossref","first-page":"600840","DOI":"10.3389\/fmolb.2020.600840","article-title":"Human cerebral cortex proteome of fragile X-associated tremor\/ataxia syndrome","volume":"7","author":"Holm","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.conb.2021.11.006_bib50","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","article-title":"CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome","volume":"78","author":"Todd Peter","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2021.11.006_bib51","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s40478-014-0162-2","article-title":"FMRpolyG-positive inclusions in CNS and non-CNS organs of a fragile X premutation carrier with fragile X-associated tremor\/ataxia syndrome","volume":"2","author":"Buijsen","year":"2014","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/j.conb.2021.11.006_bib52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s40478-019-0796-1","article-title":"Composition of the intranuclear inclusions of fragile X-associated tremor\/ataxia syndrome","volume":"7","author":"Ma","year":"2019","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/j.conb.2021.11.006_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fmolb.2020.00031","article-title":"In silico, in\u00a0vitro, and in\u00a0vivo approaches to identify molecular players in fragile X tremor and ataxia syndrome","volume":"7","author":"Haify","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.conb.2021.11.006_bib54","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fcell.2020.00482","article-title":"CGG repeat expansion, and elevated Fmr1 transcription and mitochondrial copy number in a new fragile X PM mouse embryonic stem cell model","volume":"8","author":"Gazy","year":"2020","journal-title":"Front Cell Dev Biol"}],"container-title":["Current Opinion in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438821001331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438821001331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:04:58Z","timestamp":1760706298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959438821001331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":54,"alternative-id":["S0959438821001331"],"URL":"https:\/\/doi.org\/10.1016\/j.conb.2021.11.006","relation":{},"ISSN":["0959-4388"],"issn-type":[{"value":"0959-4388","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent research in fragile X-associated tremor\/ataxia syndrome","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conb.2021.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}